Johnson & Johnson reported strong Q2 earnings, with record sales and earnings per share exceeding expectations. Management raised full-year guidance and expressed optimism about future growth, highlighting successful new product launches and a robust pipeline. This positive performance and upbeat outlook are likely to result in a significant short-term rally in the stock price.

[2]